RhumbLine Advisers
PMI

RhumbLine Advisers’s Picard Medical PMI Stock Holding History

RhumbLine Advisers’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.9K Buy
8,564
+4,090
+91% +$5.93K ﹤0.01% 3820
2025
Q4 		$7.83K Buy
+4,474
New +$21.1K ﹤0.01% 3884

Other funds holding PMI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RhumbLine Advisers's PMI Position: Q1 2026 in Review

RhumbLine Advisers increased its Picard Medical (PMI) stake by 91% in Q1 2026, buying an estimated $5.93K and bringing the position to 8,564 shares worth $8.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3820.

RhumbLine Advisers first reported a position in PMI in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • RhumbLine Advisers held 8,564 shares of Picard Medical worth $8.9K as of Q1 2026.
  • RhumbLine Advisers bought 4,090 Picard Medical shares in Q1 2026, an estimated $5.93K.
  • Picard Medical made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3820 holding.
  • RhumbLine Advisers first reported a position in Picard Medical in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.